E2F1 and melanoma: We also demonstrated that E2F1 inhibition in melanoma cells induces a cellular phenotype displaying several hallmarks of senescence, such as larger but flatter cells with more granulation and increased senescence-associated-β-gal (SA-β-Gal) activity.